Why work with European ScreeningPort?

European ScreeningPort provides:

• deep scientific insight and established links with world class research institutions
• wide ranging experience in pharmaceutical industry R&D covering multiple target classes and therapeutic areas
• support in evaluating funding opportunities
• expertise in assay development and assay miniaturization
• consultancy services to aid the adaptation of assays to High Throughput Screening (HTS) compatible formats
• access to high quality compound libraries and their utilization in High Throughput Screening activities using the state-of-the-art screening facilities installed at European ScreeningPort
• execution of Proof of Concept screens with a smaller compound library
• Implementation of High Throughput Screens supported by a comprehensive data mining system
• access to Pharmaceutical-scale medicinal chemistry and bioinformatics infrastructure and processes, without the need for capital investments 
• co-ordination of structure-activity-relationship (SAR) seeking and medicinal chemistry programs by leveraging the facilities of its partners
• a pragmatic approach to intellectual property that encourages innovation and reinforces collaborative working 

Who do we work with?

Research collaborations are invited from:

• Universities
• Government-funded research institutions
• Non-profit and charity-supported institutions
• Research foundations
• University spin-outs supported by not-for-profit organisations
  (e.g. charities)
• Academic collaborations supported by not-for-profit organisations
  (e.g. charities)